Abstract

Lithium carbonate, haloperidol, and chlorpromazine hydrochloride were compared in a double-blind controlled study with severely ill hospitalized manics. Lithium carbonate and haloperidol produced a highly significant improvement of manic symptoms without sedation. Although producing considerable sedation, chlorpromazine did little to alter the underlying mania qualitatively. Qualitative differences between lithium carbonate and haloperidol indicate that, while haloperidol has a more dramatically rapid impact on behavior-motor activity, lithium carbonate acted more evenly on the entire manic picture, with total normalization realized during active treatment. The majority of lithium carbonate-treated patients met discharge criteria at study termination, but not the patients receiving either neuroleptic drug. The rating scales are not sensitive enough to monitor manic psychopathology; this accounts for the lack of statistically significant differences among drug groups at treatment termination, despite the widely disparate discharge rates.

Keywords

Lithium carbonateHaloperidolManiaChlorpromazineLithium (medication)SedationPsychologyPsychopathologyPsychiatryBipolar disorderPharmacologyAnesthesiaMedicineChemistryNeuroscienceDopamine

Related Publications

Physostigmine in Mania

Seven men and one woman with primary affective disorder, mania, were given a slow intravenous infusion of physostigmine salicylate. In six patients, mood and thought content cha...

1978 Archives of General Psychiatry 126 citations

Publication Info

Year
1975
Type
article
Volume
32
Issue
1
Pages
34-34
Citations
153
Access
Closed

External Links

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

153
OpenAlex

Cite This

Baron Shopsin (1975). Psychoactive Drugs in Mania. Archives of General Psychiatry , 32 (1) , 34-34. https://doi.org/10.1001/archpsyc.1975.01760190036004

Identifiers

DOI
10.1001/archpsyc.1975.01760190036004